Department of Immunology
University of Washington
Seattle, WA/Gilead Corp.

Dr. Ramos received his Ph.D. in Immunology from UT Southwestern Medical Center in 2009 under the mentorship of Dr. J. David Farrar.  More recently, Dr. Ramos’s work has focused on identifying the mechanism by which interleukin-1b (IL-1β) and type I interferon cross-talk to promote protective immunity against viral infection.  These studies have identified distinct IL-1β driven gene signatures that maintain classical interferon-stimulated gene responses to allow for optimal viral control.  This work has established a new way of thinking about inflammatory and type I IFN signaling integration that may promote new avenues for the development of therapeutics against disease states in which IL-1β and type IFN responses are prevalent.  Dr. Ramos is currently a member of the Gilead Sciences Discovery Virology group where he continues his work on cytokine driven viral/host interactions and the development of curative therapeutic interventions against inflammatory and viral diseases in humans.